Zuanic & Associates rates Tilray “Neutral,” noting long-term potential but near-term uncertainties, despite cannabis growth in Germany.
Latest Ratings for TAP
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022CitigroupMaintainsBuy Nov 2021BarclaysMaintainsEqual-Weight
